We are live on
!
Find out more
Jim Simons Renaissance Technologies
AUM
$63.9B
1-Year Est. Return
45.56%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
1 Year Est. Return
+45.56%
AUM
$63.9B
AUM Growth
-$531M
(-0.82%)
Holding
3,809
Top Buys
| 1 | +$800M | |
| 2 | +$304M | |
| 3 | +$261M | |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| 1 | +$656M | |
| 2 | +$632M | |
| 3 | +$474M | |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.35% |
| 3 | Industrials | 11.12% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Marchex
MCHX
$64.7M
| $2.49M | ﹤0.01% |
1,605,904
-51,460
|
|
||
1777
TechTarget
TTGT
$260M
| $2.49M | ﹤0.01% |
641,400
-72,700
|
|
||
1778
Chegg
CHGG
$118M
| $2.48M | ﹤0.01% |
3,346,800
+10,820
|
|
||
1779
Krystal Biotech
KRYS
$10.3B
| $2.48M | ﹤0.01% |
9,600
+6,300
|
|
||
1780
Franklin Electric
FELE
$4.6B
| $2.48M | ﹤0.01% |
26,900
-75,300
|
|
||
|
ACB
1781
Aurora Cannabis
ACB
$181M
| $2.48M | ﹤0.01% |
758,181
-12,063
|
|
||
1782
Ring Energy
REI
$289M
| $2.48M | ﹤0.01% |
1,620,250
-130,457
|
|
||
1783
Agnico Eagle Mines
AEM
$83.3B
| $2.48M | ﹤0.01% |
+12,197
|
|
||
1784
LCI Industries
LCII
$2.23B
| $2.47M | ﹤0.01% |
20,100
-6,097
|
|
||
1785
Forrester Research
FORR
$130M
| $2.47M | ﹤0.01% |
436,706
-11,300
|
|
||
1786
Cass Information Systems
CASS
$637M
| $2.46M | ﹤0.01% |
55,860
-21,600
|
|
||
|
XZO
1787
Exzeo Group
XZO
$1.21B
| $2.46M | ﹤0.01% |
+167,618
|
|
||
1788
Ovid Therapeutics
OVID
$424M
| $2.45M | ﹤0.01% |
1,104,300
-380,178
|
|
||
1789
iShares Russell Mid-Cap ETF
IWR
$55.6B
| $2.45M | ﹤0.01% |
25,200
-9,600
|
|
||
|
IMSR
1790
Terrestrial Energy
IMSR
$902M
| $2.45M | ﹤0.01% |
407,900
+235,100
|
|
||
1791
IBEX
IBEX
$405M
| $2.45M | ﹤0.01% |
91,291
-1,303
|
|
||
|
HITI
1792
High Tide
HITI
$203M
| $2.44M | ﹤0.01% |
1,067,632
+122,569
|
|
||
1793
Tenax Therapeutics
TENX
$318M
| $2.44M | ﹤0.01% |
152,600
+27,021
|
|
||
1794
Sutro Biopharma
STRO
$491M
| $2.44M | ﹤0.01% |
97,824
-25,041
|
|
||
1795
Jakks Pacific
JAKK
$253M
| $2.44M | ﹤0.01% |
122,318
-39,200
|
|
||
1796
LCNB Corp
LCNB
$245M
| $2.44M | ﹤0.01% |
156,283
+18,167
|
|
||
1797
Ouster
OUST
$2.97B
| $2.44M | ﹤0.01% |
+132,600
|
|
||
1798
Haemonetics
HAE
$3.37B
| $2.43M | ﹤0.01% |
+43,200
|
|
||
|
BIOA
1799
BioAge Labs
BIOA
$923M
| $2.42M | ﹤0.01% |
138,588
+120,188
|
|
||
1800
MBIA
MBI
$310M
| $2.42M | ﹤0.01% |
409,892
+268,100
|
|